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Abstract
Background: While increasing numbers of small interfering RNA (siRNA) therapeutics enter into clinical trials, the
quantification of siRNA from clinical samples for pharmacokinetic studies remains a challenge. This challenge is
even more acute for the quantification of chemically modified and formulated siRNAs such as those typically
required for systemic delivery.
Results: Here, we describe a novel method, heating-in-Triton quantitative reverse transcription PCR (HIT qRT-PCR)
that improves upon the stem-loop RT-PCR technique for the detection of formulated and chemically modified
siRNAs from plasma and tissue. The broad dynamic range of this assay spans five orders of magnitude and can
detect as little as 70 pg duplex in 1 g of liver or in 1 ml of plasma. We have used this assay to quantify
intravenously administrated siRNA in rodents and have reliably correlated target reduction with tissue drug
concentrations. We were able to detect siRNA in rat liver for at least 10 days post injection and determined that
for a modified factor VII (FVII) siRNA, on average, approximately 500 siRNA molecules per cell are required to
achieve a 50% target reduction.
Conclusions: HIT qRT-PCR is a novel approach that simplifies the in vivo quantification of siRNA and provides a
highly sensitive and reproducible tool to measure the silencing efficiency of chemically modified and formulated
siRNAs.
Background
Several small interfering RNA (siRNA)-based therapeu-
tics are currently in various phases of preclinical and clin-
ical development [1-3]. There is an unmet need to
develop sensitive methods to detect and quantify siRNAs
in cells and tissues. Therapeutic siRNAs for systemic
delivery are typically chemically modified and formulated.
Chemical modifications of the sugar-phosphate backbone
stabilise siRNA duplexes by enhancing their nuclease
resistance and increasing their specificity by reducing off-
target effects [4]. Of all delivery systems described, the
formulation of siRNAs within cationic lipid nanoparticles
(LNPs) is the most validated method for delivery to liver
and possibly to other organs [5]. While chemical modifi-
cations contribute to increased siRNA stabilisation and
specificity, they can significantly increase duplex melting
temperature. Moreover, although formulations enhance
siRNA tissue delivery and cellular uptake, they can inhi-
bit siRNA release and detection. Currently used siRNA
quantification methods include visualisation of radiola-
belled siRNAs, hybridisation-based assays with labelled
probes using enzyme-linked immunosorbent assays (ELI-
SAs; specifically, hybridisation ELISA), methods based on
high performance liquid chromatography (HPLC), * Correspondence: ylandesman@alnylam.com
Alnylam Pharmaceuticals, Cambridge, MA, USA
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graphy mass spectrometry (LC-MS) alone or in combina-
tion with hybridisation-based assays (reviewed by
Tremblay and Oldfield [6]). The most sensitive of these
bioanalytical methods is the hybridisation ELISA with
lower limit of quantification (LLOQ) of approximately 1
ng/ml of a 20-mer oligonucleotide in plasma and
approximately 1 ng/g in liver [7]. However, these assays
are laborious and have limited sensitivity. A more sensi-
t i v ea s s a yt h a ti ss i m p l ea n df a s tt op e r f o r ma n dt h a t
allows the quantification of therapeutic siRNAs from
tissue and plasma is greatly needed.
Recently, Chen et al. developed a stem-loop quantita-
tive reverse transcription PCR (qRT-PCR) method for
the quantification of microRNAs (miRs) from tissue cul-
ture cells [8]. This assay is particularly appealing
because of its high sensitivity, selectivity, and broad
dynamic range for the detection of short RNA single
strands characteristic of mature miRs. However, when
applied to the detection of siRNA duplexes in liver, the
stem-loop RT-PCR assay demonstrated a poor dynamic
range and suboptimal amplification, suggesting ineffi-
ciencies in the RT and PCR steps [9,10]. In addition,
amplification efficiency was lower for chemically modi-
fied versus unmodified siRNAs [9]. Such differences
may result from the double-stranded nature of siRNAs,
their chemical modifications and formulations.
Here, we describe the heating-in-Triton (HIT) method
that, when used in combination with the stem-loop
qRT-PCR technique, allows robust siRNA quantification
from cell lines, tissues and plasma. Using this assay we
measured unmodified and chemically modified siRNAs,
either as unformulated (naked) siRNAs, or as formulated
duplexes within LNPs [11,12]. Importantly, this assay is
strand specific and thus requires complete denaturation
of the sense and antisense strands. The assay is highly
specific and sensitive, with a broad dynamic range of
approximately five orders of magnitude that allows the
detection of as little as 70 pg siRNA in 1 g of tissue or
1 ml of plasma. With simple and rapid sample proces-
sing, high reproducibility and applicability independent
of the chemical modification or delivery strategy
employed, this assay is robust and easily adapted for
high throughput bioanalytical quantification of siRNA
in vivo.
Results
siRNA quantification requires duplex liberation from the
formulation followed by strand separation
We evaluated the amplification of two naked siRNA
duplexes and their antisense single strands by qRT-PCR
using the stem-loop method [8]. Both siRNAs target rat
factor VII (FVII) and have identical sequences, but differ
in backbone chemical modifications that increase the
melting temperature of the modified duplex: AD1661
(modified duplex) is identical to AD1596 (duplex)
except that it contains 2′-fluoro-chemically modified
nucleotides (Table 1). First, 10-fold serial dilutions
(in water) of the two duplexes and their corresponding
antisense strands were assayed in the qRT-PCR assay at
room temperature (25°C) (Figure 1a). Comparison of the
four amplification curves confirmed that modified and
unmodified antisense strands were detected with equal
efficiency, while less antisense strands were detected
from the duplex under these same conditions. The
underestimation of duplex concentrations ranged
between 6-fold to 256-fold, and correlated with duplex
concentration: at the highest concentrations, the average
signal difference between duplex and single strand was 8
average cycle threshold units (AvCt), and at the lowest
concentrations the difference was 2.5 Av Ct (Figure 1a).
T h ed i f f e r e n c ei nt h ed e t e c t i o no ff r e ea n t i s e n s es t a n d s
and the same antisense strands in the context of a
duplex could be due to the inefficiency of RT in the pre-
sence of an equimolar amount of annealed sense strand
found in the duplex samples. Comparison of the amplifi-
cation curves of the modified and unmodified duplexes
shows that the antisense strand from the unmodified
duplex was slightly more efficiently detected than the
antisense strand from the modified duplex. The decrease
in RT efficacy for the chemically modified duplex is
likely explained by its higher melting temperature
(Table 1). Therefore, strand separation prior to RT may
improve amplification curves for the detection of anti-
sense strands from the siRNA duplex.
To test the effect of strand separation on siRNA
detection by qRT-PCR, two siRNA duplexes and their
matching antisense strands were heated for 10 minutes
at 95°C and directly added into the RT reaction. Under
these conditions, similar amplification curves were
obtained for duplexes and single strands, particularly at
concentrations equal or below 1.7 nmol siRNA per RT
reaction (3.35 fmol per PCR reaction, see the -2.5 log
siRNA point in Figure 1b), suggesting that duplex siR-
NAs can be accurately measured when the RT is per-
formed on melted duplexes (Figure 1b).
In vivo delivery typically requires siRNAs formulation
in LNPs prior to intravenous injection [11,13]. LNPs
impose an additional barrier to quantification as the
siRNA must be efficiently liberated from the particles
before quantification. To test our ability to quantify
LNP-formulated siRNAs, serial dilutions of the modified
siRNA encapsulated in an LNP containing the novel
lipid KC2 [5] (KC2 mod Dup), were compared to the
modified unformulated siRNA (mod Dup) and the mod-
ified antisense strand (mod AS) (Figure 1c). As we had
seen previously, unformulated duplex and single strands,
heated at 95°C, showed similar amplification curves over
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Page 2 of 14Table 1 Small interfering RNA (siRNA) duplexes
Text name Alnylam name Sequence Melting temperature Target
Duplex AD1596
Sense Sense: A4639 GGAUCAUCUCAAGUCUUACdTdT 70.1°C FVII
AS AS: A4640 GUAAGACUUGAGAUGAUCCdTdT Murine
Mod duplex AD1661
Mod sense Sense: A4723 GGAUfCfAUfCfUfCfAAGUfCfUfUfACfdTsdT 83.4°C FVII
Mod AS AS: A4724 GUfAAGACfUfUfGAGAUfGAUfCfCfdTsdT Murine
AD6490 AD6490
A5296 Sense: A5296 GGAAUCuuAuAuuuGAUCcAsA 70.1°C APOB
A5475 AS: A5475 uuGGAUcAAAuAuAAGAuUCcscsU Human
AD1955 AD1955
A3374 Sense: A3372 cuuAcGcuGAGuAcuucGAdTsdT 78.0°C Luciferase
A5475 AS: A3374 UCGAAGuACUcAGCGuAAGdTsdT Firefly
The sequences of the two duplexes AD1596 and AD1661 are identical, except that AD1661 contains chemical modifications. AD6490 and AD1955 are unrelated
duplexes. The gene target of each siRNA is indicated. Chemical modifications are indicated as follows: 2’-O-Me-modified nucleotides are shown by lower case
letters, 2’-fluoro-modified nucleotides are shown by ‘f’ following the modified nucleotide and phosphorothioate linkages are shown by ‘s’. All sequences are
written in the 5’-3’ direction.
Alnylam name refers to Alnylam Pharmaceuticals in-house name.
APOB = apolipoprotein B; AS = antisense; FVII = factor VII; mod = modified.
Figure 1 Efficient small interfering RNA (siRNA) quantification requires release from the formulation and strand separation.
Amplification curves of unmodified (antisense (AS)), modified AS (mod AS), duplex (Duplex), modified duplex (mod Duplex), and lipid
nanoparticle (LNP)-KC2-formulated modified duplex (KC2 mod Dup) siRNAs. siRNAs were diluted as indicated either in water or in 0.25% Triton.
Then were treated as indicated either at room temperature (25°C) or heated to 95°C for 10 min and added directly into reverse transcription
reactions: (a) water; 25°C, (b) water, 95°C, (c) water, 95°C for mod AS, mod Dup and for KC2-mod Dup, both in 25°C and 95°C, and (d) 0.25%
Triton-phosphate-buffered saline (PBS); 95°C. The linear regression of the amplification curve for chemically modified AS siRNA is shown (inear fit
(mod AS)). The average cycle threshold (AvCt) values (n = 3) indicate signals in single PCR reactions containing siRNA equivalent concentrations
ranging between 3.35 × 10
-2 to 3.35 × 10
-7 pmol.
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duplexes were amplified less efficiently. Therefore, we
had to develop a method to disrupt LNP to liberate siR-
NAs for accurate quantification.
To release the siRNA from the LNP-KC2 formulation,
we tested various detergents (data not shown) and ulti-
mately selected 0.25% Triton X-100 for addition to the
formulated siRNA prior to heating at 95°C. Under these
conditions, nearly identical amplification curves were
obtained for the modified antisense strand, modified
d u p l e xa n dL N P - K C 2 - f o r m u l a t e dm o d i f i e dd u p l e x
(Figure 1d). A linear regression fit to the three amplifi-
cation curves over five orders of magnitude showed an
average slope of 3.2, which indicated nearly 100% effi-
cient amplification under these modified conditions
(Figure 1d).
In order to confirm that the direct addition of the
siRNA heated to 95°C in 0.25% Triton did not compro-
mise reverse transcriptase activity, amplification curves
of serially diluted antisense strands were evaluated with
and without heating in triton. Similar amplification
curves for the antisense strand under these two condi-
tions confirmed that no enzyme inhibition had occurred
(Figure 2). These results confirm that efficient amplifica-
tion of antisense strands from LNP-formulated, chemi-
cally modified siRNA duplexes can be achieved under
these conditions.
High temperature is required to avoid reannealing
The melting temperature (Tm) of the chemically modi-
fied duplex AD1661 was 83.4°C (Table 1). Based on this
high Tm, it is expected that reannealing of melted
duplex will occur rapidly upon cooling, thus explaining
the reduced dynamic range of the assay (Figure 1b-d).
To confirm this interpretation, modified antisense
strand, modified duplex, and the LNP-KC2-formulated
modified duplex were heated for 10 minutes at 95°C
and were assayed either directly, or allowed to cool
to 85°C, 75°C or 25°C for 10 minutes prior to RT
(Figure 3). When assayed directly at 95°C, the amplifica-
tion curves of all compounds were almost identical and
linear over approximately 5 logs, with a slope of 3.3,
which is characteristic of 100% efficiency (Figure 3a).
However, careful analysis of the Ct values from inputs
of >3.4E
-03 pmol (>-2.5 log siRNA) at 95°C, revealed an
average of 1.4 Ct difference between modified antisense
strand and the naked and formulated modified duplexes
(Figures 1d and 3a). This difference can be explained by
amplification inefficiencies observed when measuring
highly concentrated duplexes that will more quickly
anneal. The siRNA samples that were cooled down to
85°C were also efficiently amplified along most of the
serial dilutions, except for the most concentrated duplex
inputs that showed decreased amplification efficiencies
of approximately 2 Av Ct units between the antisense
strand and the tested duplexes (Figure 3b). Incubation
at 75°C (Figure 3c) or 25°C (Figure 3d) resulted in more
significant reductions in amplification efficiency for the
duplexes at the highest concentrations tested, confirm-
ing that reannealing is both temperature and concentra-
t i o nd e p e n d e n t .T h e s ed a t as h o wt h a tc o m p l e t ea n d
continued denaturation of the duplex at high concentra-
tions is essential for optimal quantification.
Quantification of modified and formulated siRNA from
plasma and liver tissue
Having defined the conditions for efficient amplification
of encapsulated chemically modified duplex siRNA in
buffer, we next evaluated these conditions for siRNA in
plasma and liver tissue. To do so, serial dilutions of
LNP-KC2-formulated modified duplex, modified unfor-
mulated duplex, and modified antisense strand control
were spiked into either naïve rat plasma (diluted 1:10 in
0.25% Triton heated to 95°C) or liver lysate (diluted to
100 mg/ml tissue in 0.25% Triton heated to 95°C).
Spiked samples were centrifuged to remove debris and
then reheated for 10 minutes at 95°C before direct addi-
tion into the qRT-PCR reaction. Nearly identical ampli-
fication curves were observed when comparing antisense
strand alone with modified duplex and LNP-formulated
modified duplex assayed in plasma (Figure 4a). Similarly,
nearly indistinguishable amplification curves were
Figure 2 Amplification curves of modified antisense (AS)
strands. AS strands were diluted in 0.25% Triton-phosphate-
buffered saline (PBS), then were kept as indicated either at room
temperature (25°C: AS 25C) or heated to 95°C for 10 min and added
directly into reverse transcription reactions (AS 95C). The linear
regression of the amplification curve for chemically modified AS at
95°C is shown (linear fit (AS 95C)). The average cycle threshold
(AvCt) values indicate signals in single PCR reactions containing
small interfering RNA (siRNA) equivalent concentrations ranging
between 3.35 × 10
-2 to 3.35 × 10
-7 pmol. Each point is an average
n=3 .
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tissue (Figure 4b). The assays were linear over four
orders of magnitude and the amplification curves had
slopes of approximately 3.2, demonstrating efficient
amplification. Given the final plasma and liver tissue
concentration in those standard curves, we concluded
that the dynamic ranges of the two assays were 0.7 μg
to 70 pg siRNA per 1 ml of plasma and 0.7 μgt o7 0p g
of siRNA per 1 g of liver tissue (Figure 4).
To confirm that our method could be used for the
quantification of siRNAs containing chemically modified
bases other than 2′-fluoro and formulations other than
LNP-KC2, we tested two additional chemically modified
and formulated siRNAs in plasma. AD1955 is a 2′-O-
Me-modified siRNA formulated in LNP-KC2, while
AD6490 is a 2′-O-Me-modified siRNA (Table 1), encap-
sulated in a distinct LNP formulation containing the
lipid C12-200 (LNP-C12-200) [14]. Chemically modified
antisense strands, duplexes and formulated duplexes
were serially diluted in rat plasma and processed as
described above. Similar amplification curves of the
antisense strands, duplexes and formulated duplexes
demonstrated a linear detection between 0.7 μgt o7 0p g
duplex/ml of plasma for both siRNAs (Figure 5). To
further confirm the universal utility of this detection
method, two additional siRNA spiking experiments were
performed in rat liver lysates. In the first we used the
2′-fluoro-modified AD1661 duplex (Table 1) in the
LNP-KC2 formulation, but this time, we tested reagents
for the quantification of the sense strand (mod sense;
Figure 6a). In the second experiment we tested the anti-
sense strand, duplex and formulated AD6490 (Table 1)
in LNP-C12-200 formulation (Figure 6b). Both experi-
ments demonstrated a linear range over 4 logs and the
ability to quantify siRNA between the ranges of 0.7 μg/g
to 70 pg/g of liver tissue.
Quantification of siRNA and target expression in rat liver
To quantify siRNAs in vivo, an intravenous dosing study
was performed targeting FVII in rat liver. Single doses
(0.0625, 0.125, or 0.25 mg/kg) of LNP-KC2-formulated
modified duplex AD1661 were delivered to rats and
Figure 3 Reannealing of the modified duplex. The modified antisense (mod AS), modified duplex (mod Duplex) and lipid nanoparticle (LNP)-
KC2-formulated duplex (KC2 mod Dup) small interfering RNAs (siRNAs) were diluted in 0.25% Triton-phosphate-buffered saline (PBS) and were
first heated to 95°C for 10 min and then were kept for another 10 min at the indicated temperature before directly added into the RT reaction:
(a) 95°C, (b) 85°C, (c) 75°C, (d) 25°C. The linear regression of the amplification curve for chemically modified AS is shown (linear fit (mod AS)).
The average cycle threshold (AvCt) values indicate signals in single PCR reactions containing siRNA equivalent concentrations ranging between
3.35 × 10
-2 to 3.35 × 10
-7 pmol. Each point is an average n = 3.
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monitored over 20 days (Figure 7a). The drug elimina-
tion curves showed dose proportional clearance with
average residual siRNA of 0.01% at day 10 in rat liver
(Figure 7b). At all doses tested, siRNAs could be
detected up to day 10 post dosing. A lower limit of
detection (LLOD) of 25.8 ± 4.6 pg/g was calculated
from the phosphate-buffered saline (PBS)-treated rats.
FVII transcript levels measured in liver by qRT-PCR
assay decreased by as much as 80% at 1 day post siRNA
administration (Figure 7c) and were tightly correlated
with siRNA levels across the three doses and at all time
points tested (see Figure 7d; linear regression significant
at P < 0.01). Independent of the dose delivered, only
1 . 6±0 . 8n go fs i R N Ap e r1go fl i v e rw a sn e e d e dt o
achieve the ED50 of FVII gene silencing (Figure 7d).
Assuming 1.5 × 10
8 cells/g liver tissue [15], the amount
of siRNA at the ED50 is equivalent to approximately 500
siRNA molecules/liver cell. The linear regression also
indicates that to achieve 80% target depletion, approxi-
mately 15 ± 8 ng siRNA/g liver is required. Such con-
centrations were attained only on day 1 in the rats that
were injected with 0.125 and 0.25 mg/kg of AD1661
(Figure 7c).
Prediction of specificity: recognition of siRNA metabolites
The annealing of single strand RNAs to specific stem-
loop RT oligonucleotides is a prerequisite for quantita-
tive RT, which generates the first strand cDNA. Efficient
synthesis of the second cDNA strand depends on the
annealing of the newly synthesised cDNA to a specific
forward primer. In this work, we designed stem-loop oli-
gonucleotides that share 6 nucleotides of complementar-
ity with the 3′ end of the siRNA and forward primers
with 18 nucleotides of complementarity with the 5′ end
of the first strand cDNA (see Methods). In addition to
efficiently detecting full-length product, this primer
design would be expected to allow detection of
Figure 4 Amplification curves of the modified antisense (mod AS), modified duplex (mod Duplex) and lipid nanoparticle (LNP)-KC2-
formulated modified duplex (KC2 mod Duplex) in plasma and tissue. The small interfering RNAs (siRNAs) were diluted in 0.25% Triton-
phosphate-buffered saline (PBS) and (a) 10% rat plasma or (b) 100 mg/ml frozen powdered rat liver lysate. Reverse transcription reactions were
made from heated siRNA dilutions at 95°C. The linear regression of the amplification curves of formulated KC2 mod Duplex are shown (linear fit
(KC2 mod Dup)). The average cycle threshold (AvCt) values indicate signals in single PCR reactions containing siRNA equivalent concentrations
ranging between 3.35 × 10
-3 to 3.35 × 10
-7 pmol. Given the final plasma and liver tissue concentrations, the standard curves reveal dynamic
ranges of at least four orders of magnitude: 0.7 μg to 70 pg siRNA per 1 ml of plasma or 1 g of liver tissue. Background Ct values (back) are
indicated. Each point is an average n = 3.
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bolism in vivo. To evaluate the degree of metabolite
detection by this assay, a set of 19 truncated modified
antisense strands were synthesised; 13 of these oligonu-
cleotides contained 5′ truncations and 6 contained 3′
truncations (Table 2). We then tested the ability of the
HIT qRT-PCR assay to discriminate among these trun-
cated oligonucleotides. As expected based on the design
features described above, we observed asymmetry
between the ability to detect 5′ and 3′ truncated oligo-
nucleotides (Figure 8). While there was a gradual loss in
detection of 5′ end truncations (Figure 8a), an abrupt
loss of detection was observed with the elimination of
only three bases on the 3′ end of the antisense oligonu-
cleotide (Figure 8b). Truncation of 6 nucleotides at the
5′ end reduced the detection sensitivity by 10-fold com-
pared to the full-length antisense strand and the
truncation of 9 nucleotides reduced that signal by
100-fold (Figure 8a).
Discussion
The HIT qRT-PCR assay (Figure 9) represents a signifi-
cant improvement over the previously published stem-
loop qRT-PCR method [8] as it allows a reliable and
sensitive quantification of the sense or antisense strand
of formulated and chemically modified siRNAs from in
vivo samples. The improvements include protocols for
processing tissue samples without the need for RNA
purification. The resulting assay has a dynamic range
exceeding four orders of magnitude and a sensitivity
that surpasses other published methods [4,7,9]. For
plasma and tissue detection, samples are directly diluted
in 0.25% Triton and heated to 95°C to efficiently release
the encapsulated siRNA from the LNP. To achieve
Figure 5 Further examples of amplification curves of modified antisense (AS), modified duplex, and formulated modified duplex in
plasma for the indicated small interfering RNAs (siRNAs). The modified siRNAs (a) AD1955 or (b) AD6490 were diluted in 0.25% Triton-
phosphate-buffered saline (PBS)/10% rat plasma. Reverse transcription reactions were made from heated siRNA dilutions at 95°C. The linear
regressions of the amplification curves of formulated KC2 or C12-200 modified duplexes are shown (linear fit (KC2 AD1955 or C12-200 AD6490)).
The average cycle threshold (AvCt) values indicate signals in single PCR reactions containing siRNA equivalent concentrations ranging between
3.35 × 10
-3 to 3.35 × 10
-7 pmol. Background Ct values (back) are indicated. Each point is an average n = 3.
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Page 7 of 14efficient amplification, plasma and tissue samples are
then centrifuged to remove debris, and reheated to 95°C
to ensure efficient strand separation for the RT reaction.
Comparable quantitation of antisense strands alone ver-
sus modified and formulated duplexes confirms that
complete duplex denaturation occurs.
The HIT siRNA quantification method extends the
work of Chen et al., who developed the original stem-
loop qRT-PCR method for the quantification of miR-
NAs [8]. They demonstrated high assay sensitivity and
showed its broad utility by measuring the levels of 10
different miRNAs from tissue culture cells, using various
sample preparation techniques. Specifically, they
observed that quantification from a PBS-boiled tissue
culture suspension was as efficient as that from purified
RNA, thus eliminating the RNA purification step in
their protocol. While the direct boiling/cooling method
described by Chen was simple, it was clear that addi-
tional steps were needed to make this protocol suitable
for the quantification of chemically modified and formu-
lated siRNAs from animal tissue. Importantly, efficient
strand separation turned out to be critical for accurate
quantification of siRNAs by qRT-PCR. Strand reanneal-
ing occurs rapidly in cooled siRNA lysates. As a result,
the direct application of heat-denatured siRNAs into the
RT reaction was required when measuring high concen-
trations of high Tm duplexes such as AD1661. In addi-
tion, effective siRNA quantification required complete
release of the siRNA from the liposomal formulation, a
challenge not relevant to endogenous miRNA detection
assays. To accomplish this, 0.25% Triton at 95°C was
added, as heating in PBS alone was not sufficient to
fully liberate the duplex.
The rate of duplex reannealing is directly correlated
with duplex concentration and inversely correlated with
increased temperature. The highest siRNA concentra-
tion in an RT reaction used in our experiments was
17 nmol, from which 33.5 fmol were analysed in one
Figure 6 Further examples of amplification curves of modified antisense (AS), modified duplex, and formulated modified duplex in
liver tissue for the indicated small interfering RNAs (siRNAs). The modified siRNAs (a) AD1661 or (b) AD6490 were diluted in 0.25% Triton-
phosphate-buffered saline (PBS) in rat liver at final concentration of 100 mg/ml. Reverse transcription reactions were made from heated siRNA
dilutions at 95°C. For AD1661 the assay analysed the sense strand. In this experiment the modified sense strand A4723 serves as the single
strand control. The linear regressions of the amplification curves of formulated KC2 or C12-200 modified duplexes are shown (linear fit (KC2
AD1661 or C12-200 AD6490)). The average cycle threshold (AvCt) values indicate signals in single PCR reactions containing siRNA equivalent
concentrations ranging between 3.35 × 10
-3 to 3.35 × 10
-7 pmol. Background Ct values (back) are indicated. Each point is an average n = 3.
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Figure 7 Correlation between in vivo delivered small interfering RNA (siRNA) and target knockdown in rat liver. (a) Experimental setup.
Rats were tail-vein injected with phosphate-buffered saline (PBS), 0.0625, 0.125 and 0.25 mg/kg chemically modified and formulated siRNA in
lipid nanoparticle (LNP)-KC2 (LNP-KC2-AD1661) on day 0. At 1, 3, 7, 10 and 20 days after injection, frozen powdered liver from three rats from
each group was analysed for siRNA concentration and for target (factor VII (FVII)) expression. (b) Quantification of modified siRNA in rat liver.
Average of three rats, measured twice independently, with day 20 levels below lower limit detection and therefore not shown (lowest limit of
detection (PBS) = 25.8 ± 4.6 pg/g). (c) Gene target knockdown in rat liver. The average of FVII RNA expression in three rats, relative to FVII
expression in PBS injected rats. (d) Correlation between siRNA drug levels and FVII RNA levels over time in rat livers. Symbols represent means ±
1 standard error (SE) for individual rats. Blue line, linear regression; grey shading indicates 95% confidence interval. Yellow rectangles indicate
50% effective dose (EC50) and EC80 estimates.
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Page 9 of 14qRT-PCR reaction. At that concentration, reannealing of
duplexes occurred rapidly and amplification was not
fully efficient, as evidenced by the non-linearity of the
curves at this input dose (see the -1.5 points in Figures
1d and 3a). Based on this observation, the upper limit of
quantification for our standard curves was defined as 3.4
fmol per qRT-PCR reaction. This translated to approxi-
mately 0.7 μg duplex/ml plasma and 0.7 μgd u p l e x / go f
liver tissue (Figure 4). The average lowest limit of quan-
tification was 0.34 attmol of siRNA, translated to
approximately 70 pg duplex/ml plasma and 70 pg
duplex/g of liver tissue, yielding signals that are 4-fold
to 10-fold above background signal (a difference of 2-3
Av Ct units).
Having developed an assay for the quantification of
formulated and chemically modified siRNA in liver tis-
sue or plasma, the next challenge was to use this assay
for the quantification of such siRNAs delivered to rats
by intravenous dosing. The goal was to quantify the
siRNA antisense strand from siRNA duplex that targets
FVII mRNA in rat liver. The antisense strand was
selected as it represents the functional targeting strand,
but the assay is equally amenable to sense strand
detection (Figure 6a). In this in vivo experiment, 0.0625,
0.125 and 0.25 mg/kg of LNP-KC2-formulated AD1661
were delivered as single doses, and samples were quanti-
fied for both target mRNA and siRNA levels at 1, 3, 7,
10, or 20 days post dosing. A linear correlation between
the amounts of siRNA delivered and target knockdown
w a so b s e r v e di nt h er a tl i v e r s( F i g u r e7 ) .T h i sc o r r e l a -
tion indicated that independent of the dose adminis-
tered, approximately 1.6 ± 0.8 ng/g of modified AD1661
siRNA resulted in an approximately 50% reduction of
FVII mRNA (ED50 = approximately 1.6 ± 0.8 ng/g). This
translates to an average of 500 siRNA molecules/cell in
rat liver.
To confirm that extraction of siRNA using the HIT
qRT-PCR protocol is efficient, we repeated the assay on
a subset of the above rat liver tissue samples using a
phenol chloroform extraction protocol. The Ct values
measured from these two assay protocols were almost
identical suggesting that the HIT qRT-PCR assay proto-
col efficiently liberates siRNAs for easy detection (data
not shown). This experiment not only confirmed the
quantification results by another method, but also
Table 2 Set of 5’ and 3’ truncations of the modified
antisense A4724
Truncation name Sequence 5’-3’
Full-length AS GUfAAGACfUfUfGAGAUfGAUfCfCfdTsdT
5’ N-1 UfAAGACfUfUfGAGAUfGAUfCfCfdTsdT
5’ N-2 AAGACfUfUfGAGAUfGAUfCfCfdTsdT
5’ N-3 AGACfUfUfGAGAUfGAUfCfCfdTsdT
5’ N-4 GACfUfUfGAGAUfGAUfCfCfdTsdT
5’ N-5 ACfUfUfGAGAUfGAUfCfCfdTsdT
5’ N-6 CfUfUfGAGAUfGAUfCfCfdTsdT
5’ N-7 UfUfGAGAUfGAUfCfCfdTsdT
5’ N-8 UfGAGAUfGAUfCfCfdTsdT
5’ N-9 GAGAUfGAUfCfCfdTsdT
5’ N-10 AGAUfGAUfCfCfdTsdT
5’ N-11 GAUfGAUfCfCfdTsdT
5’ N-12 AUfGAUfCfCfdTsdT
5’ N-13 UfGAUfCfCfdTsdT
3’ N-1 GUfAAGACfUfUfGAGAUfGAUfCfCfdT
3’ N-2 GUfAAGACfUfUfGAGAUfGAUfCfCf
3’ N-3 GUfAAGACfUfUfGAGAUfGAUfCf
3’ N-4 GUfAAGACfUfUfGAGAUfGAUf
3’ N-5 GUfAAGACfUfUfGAGAUfGA
3’ N-6 GUfAAGACfUfUfGAGAUfG
The full-length antisense (AS) strand sequence is indicated, along with the
sequences of 5’ (5’ N-1 to 5’ N-13) and 3’ (3’ N-1 to 3’ N-6) truncated
oligonucleotides. Chemical modifications are shown as follows: 2’-fluoro-
modified nucleotides are shown by ‘f’ following the modified nucleotide and
phosphorothioate linkages are shown by ‘s’. All sequences are written in the
5’-3’ direction.
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Figure 8 The detection of full-length, 5’ and 3’ truncated
antisense oligonucleotides. (a) The 5’-truncated oligonucleotides
(5’ N-1 to 5’ N-13) and (b) 3’-truncated oligonucleotides (3’ N-1 to 3’
N-6) were tested in 10-fold serial dilutions by the heating-in-Triton
quantitative reverse transcription PCR (HIT qRT-PCR) method. The
sequences of these oligonucleotides and their nomenclature are
detailed in Table 2. The average cycle threshold (AvCt) values
indicate signals in single PCR reactions containing small interfering
RNA (siRNA)-equivalent concentrations ranging between 3.35 × 10
-2
to 3.35 × 10
-7 pmol. Each point is an average n = 3.
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release of protein bound siRNA, such as might be
bound to the Argonaute 2 (Ago2) protein.
By analysing sets of truncated antisense molecules we
aimed to predict the type of siRNA metabolites that one
may detect when using the HIT qRT-PCR method. As
expected, the assay is more sensitive to 3′ end trunca-
tions than to 5′ end truncations (Figure 8). We observed
that siRNA metabolites that include strand truncations
of up to five nucleotides at their 5′ end and up to two
nucleotides on their 3′ end are detected by the HIT
qRT-PCR method with reasonable efficiency. Future
assay development, including modifications of primer
length, will further improve HIT qRT-PCR′s ability to
specifically measure full-length and siRNA metabolites.
Conclusions
In summary, we developed a reliable, reproducible and
highly sensitive method of quantitating siRNAs delivered
in vivo. As more siRNA therapeutic programmes are
initiated and move into preclinical and clinical stages,
accurate quantification of siRNA levels across various
tissues will become crucially important. This method
allows the correlation of pharmacodynamic with precise
pharmacokinetic measures, using a sensitive and easy to
perform assay that will contribute to the successful
development of siRNA therapeutics.
Methods
Oligonucleotides (Integrated DNA Technologies, IA,
USA) and TaqMan probes (Applied Biosystems of Life
Technologies, CA, USA) (Table 3) were designed
according to Chen et al. [8].
siRNAs were formulated either in LNP-KC2 [5], or in
LNP- C12-200 [14].
Quantification of siRNA in liver tissue or plasma in
0.25% Triton: the HIT qRT-PCR protocol (Figure 9)
Following plasma collection and necropsy, plasma and
liver samples were kept frozen and liver tissue ground
Figure 9 Schematic presentation of standard curve and sample preparation protocols for the heating-in-Triton (HIT) quantification of
small interfering RNA (siRNA) from plasma and liver tissue.
Landesman et al. Silence 2010, 1:16
http://www.silencejournal.com/content/1/1/16
Page 11 of 14for 2 minutes (min) at 250 strokes/min using a Geno
Grinder (SPEXP SamplePrep, NJ, USA) to achieve a
light homogeneous powder.
Preparation of standard curves
Duplex, antisense and formulated siRNAs (20 μM) were
used for the preparation of serial 10-fold dilutions into
95°C boiled tissue (100 mg/ml) or plasma (1:10 diluted)
in 0.25% Triton X-100 in PBS, as detailed below.
For tissue, 500 μl of 0.25% Triton X-100 at 95°C was
added directly into 50 mg of naïve (PBS-treated animal)
frozen powdered tissue. The lysate was vortexed and
put back into the 95°C hot block. Then, 12.5 μlo f
20 μM siRNA was added into the hot lysate, which was
then vortexed again and put back into the hot block for
a total incubation time of 10 min. This procedure was
performed once for formulated duplex, naked duplex
and for antisense or sense strands. Additional tubes
with naïve tissue lysates in 0.25% Triton X-100 were
heated at 95°C. These were used for the preparation of
the standard curve points. Following 10 min at 95°C, all
lysates were cooled on ice for 10 min.
For plasma, plasma from naïve animals (PBS treated)
was diluted 1:10 in 0.25% Triton X-100, and 500 μl
taken into an Eppendorf tube and heated in a 95°C hot
block. Then, 12.5 μlo f2 0μM siRNA was added into
the hot lysate, which was then vortexed again and put
back into the hot block for a total incubation time of
10 min. This procedure was performed once for formu-
lated duplex, naked duplex and for antisense or sense
strands. Additional tubes with naïve plasma lysates in
0.25% Triton X-100 were heated at 95°C. These were
used for the preparation of the standard curve points.
Following 10 min at 95°C, all lysates were cooled on ice
for 10 min.
Cooled tissue and plasma lysate tubes were centri-
fuged at 20,000 g for 20 min at 4°C and supernatants
placed into clean Eppendorf tubes and kept on ice.
The naïve and siRNA-spiked (500 nmol), heated and
cleared tissue or plasma lysates were used to prepare
10-fold serial dilution points (50 nmol to 50 fmol) for
the standard curves.
Preparation of liver and plasma samples for the
quantification of siRNA
For tissue, 500 μl of 0.25% Triton X-100 at 95°C was
added directly into each 50 mg frozen powdered tissue
sample. Lysates were vortexed and put back into the
95°C hot block for a total incubation time of 10 min.
Lysates were vortexed twice more during this incuba-
tion. Following 10 min at 95°C, all lysates were cooled
on ice for 10 min.
For plasma, plasma samples were diluted 1:10 in 0.25%
Triton X-100. Then, 500 μl from each diluted plasma
Table 3 Oligonucleotides and TaqMan probes for the stem-loop real time PCR assays
Assay Primer/probe Sequence
AD1596
AD1661
Stem-loop RT GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACAAGGAT
Forward primer GCCCGCGTAAGACTTGAGATGATC
Reverse primer GTGCAGGGTCCGAGGT
TaqMan probe (6-FAM) CTGGATACGACAAGGAT (MGB)
AD6490 Stem-loop RT GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACAGGGAA
Forward primer CCCGCTTGGATCAAATATAAGATT
Reverse primer GTGCAGGGTCCGAGGT
TaqMan probe (6-FAM) CTGGATACGACAGGGAA (MGB)
AD1955 Stem-loop RT GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACAACTTA
Forward primer TCGTGTTCGAAGTACTCAGCGTAA
Reverse primer GTGCAGGGTCCGAGGT
TaqMan probe (6-FAM) CTGGATACGACAACTTA (MGB)
AD1661
(sense)
Stem-loop RT GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACAAGTAA
Forward primer GCCCGCGGATCATCTCAAGTCTTA
Reverse primer GTGCAGGGTCCGAGGT
TaqMan probe (6-FAM) CTGGATACGACAAGTAA (MGB)
All assays designed to detect the antisense strands of the indicated duplexes, except for the indicated assay designed for sense strand detection. All sequences
are written in the 5’-3’ direction.
6-FAM = 6-carboxyfluorescein; MGB = minor groove binder; RT = reverse transcription.
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Page 12 of 14sample was heated at 95°C for a total incubation time of
10 min and vortexed twice during this incubation. Fol-
lowing 10 min at 95°C, all lysates were cooled on ice for
10 min.
All tissue and plasma lysates were centrifuged at
20,000 g for 20 min at 4°C and supernatants taken into
clean Eppendorf tubes and kept on ice.
Reverse transcription reactions
Reverse transcription reactions were performed using a
TaqMan MicroRNA Reverse Transcription kit 200
(Applied Biosystems of Life Technologies, cat #
4366596).
We recommend using two adjacent PCR machines for
the procedure. One PCR machine for heating the ‘boil-
ing plate’ and the second for the ‘RT plate’, as detailed
below.
A total of 50 μl from each standard curve point (single
strand, duplex and formulated duplex), one naïve (for
background) and sample lysates were aliquoted into one
PCR plate (’boiling plate’) and heated at 95°C for 10 min
on one PCR machine. Then, 10 μl of RT reaction mix
(100 mmol deoxyribonucleotide triphosphates, 250 nmol
stem and loop oligonucleotides, 20 U/μlR N a s ei n h i b i -
t o r ,1×R Tb u f f e r ,5 0U / μl MultiScribe Reverse Tran-
scriptase) was aliquoted into each well of the ‘RT plate’,
which was placed on the second adjacent PCR machine
and kept at 4°C. Following 10 min of heating, the cover
from the ‘boiling plate’ was removed and, while the
plate was kept on the heating block, 5 μlf r o me a c hh o t
sample was directly added into the RT reaction mix (at
4°C) on the ‘RT plate’ and the program was switched
onto the RT program (30 min, 16°C, 30 min, 42°C,
5 min, 85°C).
PCR amplification
At o t a lo f2μl of cDNA from the previous step was
added into the PCR amplification reaction mix (0.2 μM
TaqMan probe, 1.5 μMf o r w a r dp r i m e r ,0 . 7μMr e v e r s e
primer, TaqMan 2 × Universal PCR Master Mix, No
AmpErase UNG; Applied Biosystems of Life Technolo-
gies, cat # 4366596). The ABI 7900HT Sequence Detec-
tion System and the ‘Standard Curve’ application SDS
2.3 (Applied Biosystems of Life Technologies) were used
to run the PCR reaction.
Quantification of Gene knockdown in rat liver
An RNeasy mini kit (Qiagen Inc. Valencia, CA, USA, cat
# 74106) was used to purify total RNA from frozen
powdered rat liver. A High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems of Life Technolo-
gies, cat # 4368814) was used for RT. TaqMan Assays
Rat FVII (cat # Rn00596104_m1) and TaqMan Assay
Rat GAPDH kit (cat # 4352338E) together with TaqMan
Universal PCR Master Mix No AmpErase UNG (cat #
4324020, all from Applied Biosystems of Life Technolo-
gies) were used for the amplification of rat FVII and
GAPDH transcripts.
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